Taevas' Expertise in the Pharmaceuticals Market
Specializing in turning market entry challenges into growth opportunities and helping your business thrive in the new markets with strategic market access solutions.
8+
Pharmaceuticals Companies Launched
10
Months average time to market
112+
Products available for new partnerships
43%
Cost saving
Market Access Solutions
The Taevas Advantage
Taevas stands ready to serve as your custom-fit partner in India, catering to your unique business requirements.
As your Indian Authorized Representative (IAR), we ensure your regulatory complianc
We identify potential distributors for your products and facilitate initial connection
Clients can lead the further development of these distributor relationships
- Along with being your IAR, we also act as your centralized distributor in India
- We identify and appoint local distributors in different regions of India, creating a wide and efficient distribution network
- You can focus on your core business, while we handle the complexities of distribution
- Along with being your IAR, we also initiate the building of your local presence in India
- We put together a dedicated team who takes charge of sales partnerships and manages the nuances of business operations
- We ‘Build’ the infrastructure and set up processes; we ‘Operate’ the business, and when you feel ready, we ‘Transfer’ the control to you
Transcending borders
Taevas helps global life sciences innovators with global expansion strategies to connect with audiences worldwide and make it accessible for millions of people around the world.
Transcending borders
Taevas helps global life sciences innovators with global expansion strategies to connect with audiences worldwide and make it accessible for millions of people around the world.
JAPAN
BRAZIL
UK
CANADA
MEXICO
SINGAPORE
MALAYSIA
SOUTH AFRICA
SRI LANKA
AUSTRALIA
POLAND
FRANCE
SWITZERLAND
CHINA
Transcending borders
Taevas helps global life sciences innovators with global expansion strategies to connect with audiences worldwide and make it accessible for millions of people around the world.
USA
UAE
Germany
Japan
Brazil
United Kingdom
Canada
Mexico
Singapore
Malaysia
South Africa
Srilanka
Australia
Poland
France
Switzerland
China
Frequently Asked Questions
How do you handle differences in drug approval processes across different countries?
We have a team that specializes in understanding and navigating the drug approval processes in different countries. They stay updated on all changes to ensure your products meet every requirement.
How do you approach marketing strategies considering the direct-to-consumer advertising restrictions in certain countries?
We have ample experience creating impactful marketing strategies that comply with advertising restrictions in different markets. We leverage a variety of channels, including professional networks, thought leadership, and educational content.
What is your experience with the drug patenting process and patent disputes internationally?
Our team includes intellectual property experts experienced in managing patent filings and disputes on an international scale. We ensure your product’s intellectual property is adequately protected.
Do you have a strategy for obtaining formulary approval from insurance companies and healthcare providers in the target countries?
Our approach includes developing a detailed understanding of the insurance and healthcare provider landscape in each target market. We have strategies to secure formulary approval and can facilitate negotiations where necessary.
How do you ensure compliance with differing privacy laws related to patient information in various countries?
We have a strict compliance protocol for managing and protecting patient information. Our data handling procedures are fully compliant with GDPR, HIPAA, and other relevant privacy laws in different countries.
Market Insights
Our Client Reviews
“Taevas’ Sales Playbook was a game-changer for our team! It streamlined our approach and armed us with winning strategies. Our sales soared, all thanks to their insightful guidance.”
